ReviewOncology2026

Hydroxyurea Bridging Before Frontline Tyrosine Kinase Inhibitor Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal.

Mohammed Abdulgayoom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.